出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年1月
Electrophysiology Market – Forecast to 2028
電気生理学市場 : 製品（検査用機器、アブレーション用カテーテル、診断用カテーテル）、適応症（心房細動、心房粗動、AVNRT、WPW）、エンドユーザー（病院＆心臓病センター）、地域別 – 2028年までの世界予測
Electrophysiology Market by Product (Laboratory Devices, Ablation Catheters, Diagnostic Catheters), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT, WPW), End-user (Hospitals & Cardiac Centers), and Region – Global Forecast to 2028
| ページ数 | 239 |
| 図表数 | 225 |
| 種別 | 英文調査報告書 |
| 価格 |
Report Overview
The global Electrophysiology market is projected to reach USD 15.1 billion by 2028 from USD 8.2 billion in 2023, growing at a CAGR of 15.2% during the forecast period.
世界の電気生理学市場は、2023年の82億米ドルから2028年までに151億米ドルに達すると予測されており、予測期間中に15.2%のCAGRで成長します。
The projected increase in market growth for the Electrophysiology market is seen due to technological advancements and Increased research funding. The increasing frequency of implantable cardiac devices such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization treatment (CRT) devices contributes to the electrophysiology market’s growth.
“The electrophysiology laboratory devices segment to register highest growth over the forecast period of 2023-2028.”
Based on the product, the Electrophysiology market is segmented into electrophysiology laboratory devices, electrophysiology ablation catheters,electrophysiology diagnostic catheters, EP access products, and other devices. Electrophysiology laboratory devices is to witness the highest growth during the forecast period. Electrophysiology equipment used in clinical settings, such as cardiac electrophysiology investigations and ablation procedures, has been expected to grow. The need for better clinical electrophysiological tools is fueled by ageing populations and advancements in treatment modalities.
“Asia Pacific to register highest CAGR in the market during the forecast period.”
For the forecasting period 2023-2028, the APAC region is expected to register a significant growth rate in the market during the forecast period. Asia Pacific comprises India, China, Japan, Australia, South Korea, and RoAPAC. The Asia-Pacific (APAC) region has witnessed a significant increase in the market growth rate for the electrophysiology market.
There are several drivers that contributed to this growth:
The cost of healthcare has been rising in many APAC nations, including China, India, Japan, and South Korea. Advanced medical technology, like electrophysiological devices, are being adopted at a higher rate as the healthcare infrastructure gets better. APAC is seeing an increase in cardiovascular disorders due to ageing populations, changing lifestyles, and urbanisation. The diagnosis and treatment of cardiac disorders frequently depend on electrophysiology procedures, which raises the need for associated devices.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%
• By Designation: C-level–27%, Director-level–18%, and Others–55%
• By Region: North America–50%, Europe–20%, Asia Pacific–15%, Latin America–10%, and the Middle East & Africa–5%
Research Coverage
• The report studies the Electrophysiology market based on Product, Indication, End User and Region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro markets concerning their growth trends, prospects, and contributions to the global electrophysiology market.
• The report forecasts the revenue of market segments with respect to five major regions.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants/smaller firms in this market with investment evaluation viability within the Electrophysiology market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing application, end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, growth catalysts, challenges, and prospects, thereby empowering strategic decision-making with astute discernment.
The report provides insights on the following pointers:
• Analysis of key drivers (Technology advancements) (Growing investments,funds), opportunities (Expansion of key players in emerging countries, Rising healthcare expenditure across developing countries), and challenges (Availability of alternative technology) influencing the growth of the Electrophysiology market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the electrophysiology market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the Electrophysiology market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the electrophysiology market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Johnson & Johnson (US), Abbott Laboratories (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Boston Scientific (US) among others.
Table of Contents
1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.2.1 INCLUSIONS AND EXCLUSIONS 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 REGIONS COVERED 24
1.3.3 YEARS CONSIDERED 25
1.3.4 CURRENCY CONSIDERED 25
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 25
1.4 STAKEHOLDERS 25
1.5 SUMMARY OF CHANGES 26
1.5.1 RECESSION IMPACT 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH APPROACH 28
FIGURE 1 RESEARCH DESIGN 28
FIGURE 2 ELECTROPHYSIOLOGY MARKET: MARKET GROWTH IMPACT ANALYSIS 29
2.1.1 SECONDARY DATA 29
2.1.1.1 Key data from secondary sources 30
2.1.2 PRIMARY DATA 31
2.1.2.1 Primary sources 31
2.1.2.2 Breakdown of primaries 32
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 32
2.2 MARKET SIZE ESTIMATION 32
FIGURE 4 MARKET SIZE ESTIMATION: VENDOR REVENUE-BASED MARKET ESTIMATION 33
2.2.1 END USER-BASED MARKET ESTIMATION 33
FIGURE 5 MARKET SIZE ESTIMATION: END USER-BASED MARKET ESTIMATION 33
FIGURE 6 BOTTOM-UP APPROACH 34
FIGURE 7 TOP-DOWN APPROACH 34
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 36
FIGURE 8 DATA TRIANGULATION METHODOLOGY 36
2.4 LIMITATIONS 37
2.5 RISK ASSESSMENT 37
2.6 STUDY ASSUMPTIONS 37
2.7 ELECTROPHYSIOLOGY MARKET: RECESSION IMPACT ANALYSIS 38
3 EXECUTIVE SUMMARY 39
FIGURE 9 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 39
FIGURE 10 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023 VS. 2028 (USD MILLION) 40
FIGURE 11 ELECTROPHYSIOLOGY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 41
FIGURE 12 ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD (2023–2028) 42
4 PREMIUM INSIGHTS 43
4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW 43
FIGURE 13 TECHNOLOGICAL ADVANCEMENTS TO DRIVE GLOBAL ELECTROPHYSIOLOGY MARKET GROWTH 43
4.2 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY INDICATION AND REGION 44
FIGURE 14 ATRIAL FIBRILLATION SEGMENT DOMINATED ELECTROPHYSIOLOGY MARKET IN 2022 44
4.3 ELECTROPHYSIOLOGY MARKET: GEOGRAPHICAL SNAPSHOT 45
FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD (2023–2028) 45
5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
FIGURE 16 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
5.2.1 DRIVERS 47
5.2.1.1 Technological advancements 47
5.2.1.1.1 Rising use of noninvasive cardiac mapping 47
5.2.1.1.2 Increased use of improved intracardiac ablation systems 47
5.2.1.1.3 Increased use of MRI-guided ablation procedures 48
5.2.1.1.4 Growing level of ultrasound guidance in EP labs 48
5.2.1.2 Rising number of new entrants 49
5.2.1.3 Growing investments, funds, and grants for cardiac surgeries and electrophysiology 49
5.2.1.4 Increasing disease incidence and procedural volume 49
5.2.2 RESTRAINTS 50
5.2.2.1 High product cost and inadequate reimbursement 50
5.2.2.2 Unfavorable healthcare reforms in US 51
5.2.2.3 Cost-intensive data requirements for product launches and availability of alternative technologies 51
5.2.3 OPPORTUNITIES 51
5.2.3.1 Emerging markets 51
5.2.4 CHALLENGES 52
5.2.4.1 Increasing device reuse and reprocessing 52
5.2.4.2 Lack of skilled and experienced personnel 53
5.3 PORTER’S FIVE FORCES ANALYSIS 53
TABLE 2 ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 53
5.3.1 THREAT OF NEW ENTRANTS 54
5.3.2 THREAT OF SUBSTITUTES 54
5.3.3 BARGAINING POWER OF SUPPLIERS 54
5.3.4 BARGAINING POWER OF BUYERS 54
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 55
5.4 ECOSYSTEM/MARKET MAP 55
FIGURE 17 ELECTROPHYSIOLOGY MARKET: ECOSYSTEM/MARKET MAP 55
5.5 VALUE CHAIN ANALYSIS 56
5.5.1 RESEARCH & DEVELOPMENT 56
5.5.2 PROCUREMENT AND PRODUCT DEVELOPMENT 56
5.5.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES 56
FIGURE 18 ELECTROPHYSIOLOGY MARKET: VALUE CHAIN ANALYSIS 56
5.6 SUPPLY CHAIN ANALYSIS 57
5.6.1 PROMINENT COMPANIES 57
5.6.2 END USERS 57
FIGURE 19 ELECTROPHYSIOLOGY MARKET: SUPPLY CHAIN ANALYSIS 57
5.7 TARIFF & REGULATORY LANDSCAPE 57
5.7.1 NORTH AMERICA 57
5.7.1.1 US 57
TABLE 3 CLASSIFICATION OF MEDICAL DEVICES BY US FDA (2022) 58
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS (2022) 58
5.7.1.2 Canada 59
TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS (2022) 59
5.7.2 EUROPE 59
5.7.3 ASIA PACIFIC 60
5.7.3.1 India 60
5.7.3.2 China 61
TABLE 6 CHINA: NMPA CLASSIFICATION OF MEDICAL DEVICES (2022) 61
5.7.3.3 Japan 61
TABLE 7 JAPAN: PMDA CLASSIFICATION OF MEDICAL DEVICES (2022) 62
5.7.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
5.8 REIMBURSEMENT SCENARIO 64
TABLE 12 ELECTROPHYSIOLOGY MARKET: CPT CODES 64
5.9 PRICING ANALYSIS 66
5.9.1 AVERAGE PRICE OF ELECTROPHYSIOLOGY PRODUCTS, 2022 (USD) 66
5.10 TECHNOLOGY ANALYSIS 67
TABLE 13 ELECTROPHYSIOLOGY MARKET: PROMINENT PRODUCT LAUNCHES (JANUARY 2019–DECEMBER 2023) 67
5.11 PATENT ANALYSIS 67
5.11.1 PATENTS GRANTED FOR ELECTROPHYSIOLOGY 67
FIGURE 20 ELECTROPHYSIOLOGY MARKET: TOP 10 PATENT APPLICANTS 68
FIGURE 21 ELECTROPHYSIOLOGY MARKET: TOP 10 PATENT OWNERS 69
5.12 KEY CONFERENCES AND EVENTS IN 2023–2024 69
TABLE 14 ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS 69
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 70
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS, BY END USER 70
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 70
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 70
5.13.2 BUYING CRITERIA 70
FIGURE 23 KEY BUYING CRITERIA, BY END USER 70
TABLE 16 KEY BUYING CRITERIA, BY STAKEHOLDER 71
5.14 ELECTROPHYSIOLOGY MARKET: UNMET NEEDS 71
6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT 73
6.1 INTRODUCTION 74
TABLE 17 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 74
6.2 LABORATORY DEVICES 75
TABLE 18 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 75
TABLE 19 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY INDICATION, 2021–2028 (USD MILLION) 75
TABLE 20 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 76
TABLE 21 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 76
6.2.1 3D MAPPING SYSTEMS 77
6.2.1.1 Development of alternative technologies to hinder market growth 77
TABLE 22 3D MAPPING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 77
6.2.2 RECORDING SYSTEMS 78
6.2.2.1 Increasing public-private funding to support growth 78
TABLE 23 RECORDING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 78
6.2.3 RF ABLATION SYSTEMS 79
6.2.3.1 Rising number of RF ablation procedures to drive market 79
TABLE 24 RF ABLATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 79
6.2.4 ICE ULTRASOUND IMAGING SYSTEMS 80
6.2.4.1 Advantages of ICE ultrasound imaging to drive market 80
TABLE 25 ICE ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 80
6.2.5 X-RAY SYSTEMS 81
6.2.5.1 Growing availability of magnetic navigation systems to hamper market growth 81
TABLE 26 X-RAY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 81
6.2.6 REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS 81
6.2.6.1 Favorable reimbursement scenario to drive market 81
TABLE 27 REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 82
6.3 ABLATION CATHETERS 83
TABLE 28 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 83
TABLE 29 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY INDICATION, 2021–2028 (USD MILLION) 83
TABLE 30 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY END USER, 2021–2028 (USD MILLION) 84
TABLE 31 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 84
6.3.1 CRYOABLATION CATHETERS 85
6.3.1.1 Significant therapeutic advantages to drive market 85
TABLE 32 CRYOABLATION CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 85
6.3.2 RF ABLATION CATHETERS 86
6.3.2.1 Technological advancements to drive market 86
TABLE 33 RF ABLATION CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 86
6.3.3 MWA SYSTEMS 86
6.3.3.1 Advantages of microwave ablation over RF to support growth 86
TABLE 34 COMPARISON OF MICROWAVE AND RADIOFREQUENCY ABLATION 87
TABLE 35 MWA SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 87
6.3.4 LASER ABLATION SYSTEMS 88
6.3.4.1 Technologically advanced products to drive market 88
TABLE 36 LASER ABLATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 88
6.4 DIAGNOSTIC CATHETERS 89
TABLE 37 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 38 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY INDICATION, 2021–2028 (USD MILLION) 89
TABLE 39 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY END USER, 2021–2028 (USD MILLION) 90
TABLE 40 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 90
6.4.1 CONVENTIONAL DIAGNOSTIC CATHETERS 91
6.4.1.1 Increasing demand in emerging markets to support market growth 91
TABLE 41 CONVENTIONAL DIAGNOSTIC CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 91
6.4.2 ADVANCED DIAGNOSTIC CATHETERS 92
6.4.2.1 Advantages over conventional catheters to drive market 92
TABLE 42 ADVANCED DIAGNOSTIC CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 92
6.4.3 ULTRASOUND DIAGNOSTIC CATHETERS 92
6.4.3.1 Increased demand due to the rising use of ICE ultrasound imaging to drive market 92
TABLE 43 ULTRASOUND DIAGNOSTIC CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
6.5 ACCESS DEVICES 93
6.5.1 LAUNCH OF ADVANCED PRODUCTS TO DRIVE MARKET 93
TABLE 44 ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY INDICATION, 2021–2028 (USD MILLION) 94
TABLE 45 ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 94
TABLE 46 ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 95
6.6 OTHER PRODUCTS 95
TABLE 47 OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY INDICATION, 2021–2028 (USD MILLION) 95
TABLE 48 OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY END USER, 2021–2028 (USD MILLION) 96
TABLE 49 OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 96
7 ELECTROPHYSIOLOGY MARKET, BY INDICATION 97
7.1 INTRODUCTION 98
TABLE 50 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021–2028 (USD MILLION) 98
7.2 ATRIAL FIBRILLATION 98
7.2.1 GROWING INITIATIVES TO SHOWCASE ADVANTAGES OF CATHETER ABLATION OVER ANTIARRHYTHMIC DRUGS TO DRIVE MARKET 98
TABLE 51 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2021–2028 (USD MILLION) 99
7.3 ATRIAL FLUTTER 100
7.3.1 HIGH SUCCESS RATE OF RF CATHETER ABLATION TO DRIVE MARKET 100
TABLE 52 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY REGION, 2021–2028 (USD MILLION) 100
7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA 101
7.4.1 EFFICACY OF ELECTROPHYSIOLOGY DEVICES IN AVNRT APPLICATIONS TO DRIVE MARKET 101
TABLE 53 ELECTROPHYSIOLOGY MARKET FOR AVNRT, BY REGION, 2021–2028 (USD MILLION) 101
7.5 WOLFF-PARKINSON-WHITE SYNDROME 102
7.5.1 GROWING PREFERENCE FOR RF ABLATION TREATMENT OVER SURGERY TO DRIVE MARKET 102
TABLE 54 ELECTROPHYSIOLOGY MARKET FOR WPW SYNDROME, BY REGION, 2021–2028 (USD MILLION) 102
7.6 OTHER INDICATIONS 103
TABLE 55 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY REGION, 2021–2028 (USD MILLION) 103
8 ELECTROPHYSIOLOGY MARKET, BY END USER 104
8.1 INTRODUCTION 105
TABLE 56 ELECTROPHYSIOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 105
8.2 HOSPITALS & CARDIAC CENTERS 105
8.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE END-USER MARKET 105
TABLE 57 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2021–2028 (USD MILLION) 106
8.3 AMBULATORY SURGERY CENTERS 106
8.3.1 INCREASING NUMBER OF CENTERS TO DRIVE ADOPTION OF ELECTROPHYSIOLOGY DEVICES 106
TABLE 58 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021–2028 (USD MILLION) 107
9 ELECTROPHYSIOLOGY MARKET, BY REGION 108
9.1 INTRODUCTION 109
TABLE 59 ELECTROPHYSIOLOGY MARKET, BY REGION, 2021–2028 (USD MILLION) 109
9.2 NORTH AMERICA 110
FIGURE 24 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT 110
9.2.1 NORTH AMERICA: RECESSION IMPACT 111
TABLE 60 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 61 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 111
TABLE 62 NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 63 NORTH AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 64 NORTH AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
TABLE 65 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021–2028 (USD MILLION) 113
TABLE 66 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 114
9.2.2 US 114
9.2.2.1 Technological advancements to drive market growth 114
TABLE 67 US: CLINICAL TRIALS RELATED TO ELECTROPHYSIOLOGY DEVICES 114
TABLE 68 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 115
TABLE 69 US: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 70 US: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 71 US: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
9.2.3 CANADA 117
9.2.3.1 Growing government funding for research to support market growth 117
TABLE 72 RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY 118
TABLE 73 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 119
TABLE 74 CANADA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 119
TABLE 75 CANADA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 76 CANADA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
9.3 EUROPE 121
9.3.1 EUROPE: RECESSION IMPACT 121
TABLE 77 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 78 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 122
TABLE 79 EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 80 EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 81 EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 82 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021–2028 (USD MILLION) 124
TABLE 83 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 124
9.3.2 GERMANY 125
9.3.2.1 Rising healthcare expenditure and growing use of electrophysiology devices to drive market 125
TABLE 84 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 125
TABLE 85 GERMANY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 86 GERMANY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 87 GERMANY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
9.3.3 UK 127
9.3.3.1 Growing geriatric population to drive market 127
TABLE 88 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 128
TABLE 89 UK: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 90 UK: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 91 UK: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
9.3.4 FRANCE 129
9.3.4.1 Increasing incidence of heart failure to support market growth 129
TABLE 92 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 93 FRANCE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 94 FRANCE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 95 FRANCE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
9.3.5 ITALY 131
9.3.5.1 Rising incidence of CVD to drive electrophysiology device adoption 131
TABLE 96 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 132
TABLE 97 ITALY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 98 ITALY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 99 ITALY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
9.3.6 SPAIN 134
9.3.6.1 Growing number of cardiac ablation procedures to drive market growth 134
TABLE 100 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 134
TABLE 101 SPAIN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 102 SPAIN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 103 SPAIN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
9.3.7 REST OF EUROPE 135
TABLE 104 REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 105 REST OF EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 106 REST OF EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 107 REST OF EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
9.4 ASIA PACIFIC 138
9.4.1 ASIA PACIFIC: RECESSION IMPACT 138
FIGURE 25 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT 139
TABLE 108 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 109 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 140
TABLE 110 ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 111 ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 112 ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 113 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021–2028 (USD MILLION) 142
TABLE 114 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 143
9.4.2 JAPAN 143
9.4.2.1 Favorable reimbursement scenario to support market growth 143
TABLE 115 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 144
TABLE 116 JAPAN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 117 JAPAN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 118 JAPAN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 145
9.4.3 CHINA 146
9.4.3.1 Growing geriatric population to drive market 146
TABLE 119 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 146
TABLE 120 CHINA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 121 CHINA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 122 CHINA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 148
9.4.4 INDIA 148
9.4.4.1 Increasing healthcare initiatives by government to drive market growth 148
TABLE 123 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 148
TABLE 124 INDIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 125 INDIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 126 INDIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 150
9.4.5 AUSTRALIA 150
9.4.5.1 Increasing target disease burden to support market growth 150
TABLE 127 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 151
TABLE 128 AUSTRALIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 129 AUSTRALIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 130 AUSTRALIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
9.4.6 SOUTH KOREA 153
9.4.6.1 Supportive government initiatives to drive market growth 153
TABLE 131 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 153
TABLE 132 SOUTH KOREA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 133 SOUTH KOREA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 134 SOUTH KOREA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
9.4.7 REST OF ASIA PACIFIC 154
TABLE 135 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 155
TABLE 136 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 137 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 138 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
9.5 LATIN AMERICA 156
9.5.1 LATIN AMERICA: RECESSION IMPACT 157
TABLE 139 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 140 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 157
TABLE 141 LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 142 LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 143 LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 144 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021–2028 (USD MILLION) 159
TABLE 145 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 160
9.5.2 BRAZIL 160
9.5.2.1 Modernization of healthcare facilities to drive market growth 160
TABLE 146 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 160
TABLE 147 BRAZIL: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 148 BRAZIL: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 149 BRAZIL: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
9.5.3 MEXICO 162
9.5.3.1 Favorable investment scenario for medical device manufacturers to drive market 162
TABLE 150 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 163
TABLE 151 MEXICO: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 152 MEXICO: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 153 MEXICO: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
9.5.4 REST OF LATIN AMERICA 165
TABLE 154 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 165
TABLE 155 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 156 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 157 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
9.6 MIDDLE EAST & AFRICA 167
9.6.1 RISING POPULATION AND DISEASE INCIDENCE TO ATTRACT MARKET PLAYERS 167
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 167
TABLE 158 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 168
TABLE 159 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 160 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 161 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 162 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021–2028 (USD MILLION) 170
TABLE 163 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 170
10 COMPETITIVE LANDSCAPE 171
10.1 KEY PLAYER STRATEGIES/RIGHT TO WIN 171
FIGURE 26 OVERVIEW OF STRATEGIES DEPLOYED BY ELECTROPHYSIOLOGY MARKET PLAYERS 171
10.2 REVENUE SHARE ANALYSIS 172
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS, 2020–2022 172
10.3 MARKET SHARE ANALYSIS 173
FIGURE 28 ELECTROPHYSIOLOGY MARKET SHARE ANALYSIS, 2022 173
TABLE 164 ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION 173
10.4 COMPANY EVALUATION MATRIX 174
10.4.1 STARS 174
10.4.2 EMERGING LEADERS 175
10.4.3 PERVASIVE PLAYERS 175
10.4.4 PARTICIPANTS 175
FIGURE 29 ELECTROPHYSIOLOGY MARKET: COMPETITIVE EVALUATION MATRIX, 2022 175
10.4.5 COMPANY FOOTPRINT 176
TABLE 165 PRODUCT FOOTPRINT 176
TABLE 166 END-USER FOOTPRINT 177
TABLE 167 REGIONAL FOOTPRINT 178
10.5 START-UP/SME EVALUATION MATRIX 179
10.5.1 PROGRESSIVE COMPANIES 179
10.5.2 RESPONSIVE COMPANIES 179
10.5.3 DYNAMIC COMPANIES 179
10.5.4 STARTING BLOCKS 179
FIGURE 30 ELECTROPHYSIOLOGY MARKET: START-UP/SME EVALUATION MATRIX, 2022 180
10.5.5 COMPETITIVE BENCHMARKING 181
TABLE 168 ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY START-UPS/SMES 181
TABLE 169 ELECTROPHYSIOLOGY MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 182
10.6 COMPETITIVE SCENARIO AND TRENDS 183
10.6.1 PRODUCT LAUNCHES & APPROVALS 183
TABLE 170 ELECTROPHYSIOLOGY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–DECEMBER 2023 183
10.6.2 DEALS 183
TABLE 171 ELECTROPHYSIOLOGY MARKET: DEALS, JANUARY 2019–DECEMBER 2023 183
11 COMPANY PROFILES 185
(Business overview, Products/Solutions/Services offered, Recent developments & MnM View)*
11.1 KEY PLAYERS 185
11.1.1 JOHNSON & JOHNSON 185
TABLE 172 JOHNSON & JOHNSON: COMPANY OVERVIEW 185
FIGURE 31 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 186
11.1.2 ABBOTT LABORATORIES 190
TABLE 173 ABBOTT LABORATORIES: COMPANY OVERVIEW 190
FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022) 191
11.1.3 MEDTRONIC PLC 194
TABLE 174 MEDTRONIC PLC: COMPANY OVERVIEW 194
FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT (2022) 195
11.1.4 KONINKLIJKE PHILIPS N.V. 198
TABLE 175 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 198
FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 199
11.1.5 GE HEALTHCARE 202
TABLE 176 GE HEALTHCARE: COMPANY OVERVIEW 202
FIGURE 35 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 203
11.1.6 BOSTON SCIENTIFIC CORPORATION 205
TABLE 177 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 205
FIGURE 36 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2022) 206
11.1.7 JAPAN LIFELINE 209
TABLE 178 JAPAN LIFELINE: COMPANY OVERVIEW 209
FIGURE 37 JAPAN LIFELINE: COMPANY SNAPSHOT (2022) 209
11.1.8 STEREOTAXIS 211
TABLE 179 STEREOTAXIS: COMPANY OVERVIEW 211
FIGURE 38 STEREOTAXIS: COMPANY SNAPSHOT (2022) 211
11.1.9 MICROPORT SCIENTIFIC CORPORATION 214
TABLE 180 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 214
FIGURE 39 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 215
11.1.10 BIOTRONIK 218
TABLE 181 BIOTRONIK: COMPANY OVERVIEW 218
11.1.11 ACUTUS MEDICAL 220
TABLE 182 ACUTUS MEDICAL: COMPANY OVERVIEW 220
11.1.12 EP SOLUTIONS SA 222
TABLE 183 EP SOLUTIONS SA: COMPANY OVERVIEW 222
11.1.13 APN HEALTH, LLC 223
TABLE 184 APN HEALTH: COMPANY OVERVIEW 223
11.1.14 OSYPKA 224
TABLE 185 OSYPKA: COMPANY OVERVIEW 224
11.1.15 EPMAP-SYSTEM GMBH & CO. KG 225
TABLE 186 EPMAP-SYSTEM GMBH & CO. KG: COMPANY OVERVIEW 225
*Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 226
11.2.1 CATHRX LTD. 226
11.2.2 MERIT MEDICAL SYSTEMS 226
11.2.3 COOK MEDICAL 227
11.2.4 CATHVISION 227
11.2.5 TZ MEDICAL 228
11.2.6 TELEFLEX 228
11.2.7 LEPU MEDICAL TECHNOLOGY 229
11.2.8 CARDIOFOCUS 229
11.2.9 SCHWARZER CARDIOTEK 230
11.2.10 IMRICOR MEDICAL SYSTEMS 230
12 APPENDIX 231
12.1 DISCUSSION GUIDE 231
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
12.3 CUSTOMIZATION OPTIONS 237
12.4 RELATED REPORTS 237
12.5 AUTHOR DETAILS 238